Arbutus Biopharma CorporationABUSNASDAQ
LOADING
|||
Revenue Contraction
Trending lower, below historical average, structural decline.
Left:
||||
Total revenue from sales of goods and services
Latest
$6.17M
↓ 53% below average
Average (9y)
$13.02M
Historical baseline
Range
High:$39.02M
Low:$1.50M
CAGR
-14.3%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | $6.17M | -66.0% |
| 2023 | $18.14M | -53.5% |
| 2022 | $39.02M | +255.1% |
| 2021 | $10.99M | +58.9% |
| 2020 | $6.91M | +15.0% |
| 2019 | $6.01M | +1.9% |
| 2018 | $5.90M | -44.9% |
| 2017 | $10.70M | +613.3% |
| 2016 | $1.50M | -94.0% |
| 2015 | $24.87M | - |